Newswise — On September 19 and 20, 2019 SCCA's second Immunotherapy Symposium will unite numerous experts to present the ever-expanding and changing practice of immunotherapy modalities, providing the latest guidance on clinical management of checkpoint inhibitors, adoptive cell transfer (CAR T-cell) and immunotherapy treatments.
During the event, SCCA will also present the latest on analysis and late-breaking care strategies for toxicity management, dosing and monitoring of disease status. Presenters will also discuss the immunotherapy model of clinical program initiation and coordination between ambulatory and hospital settings.
More information on the event and a full agenda can be found here: https://www.seattlecca.org/healthcare-professionals/symposiums
Available for interviews –July and August
Dr. Terry McDonnell, Chief Nurse Executive and VP of Clinical Operations at Seattle Cancer Care Alliance will be available during the months of July, August and September to talk in more detail about the symposium. Dr. McDonnell is responsible for overseeing all nursing staff, guiding patient care delivery, ensuring staff accountability for providing a patient-centered clinical practice environment, and overseeing general clinical quality and patient safety.
RSS